Deinove S.A.
PAR: ALDEI.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Alexis Rideau
- Employees
- 44
- Headquarters
- Grabels, France
- IPO year
- 2010
- Market cap
- €1.1M
- Website
- https://www.deinove.com
Loading ALDEI…
Loading profile data…Frequently asked questions about ALDEI
What does Deinove S.A. (ALDEI.PA) do?
DEINOVE SA, a biotech company, discovers, develops, and produces compounds originating from microbials for the health, nutrition, and cosmetics industries worldwide. The company's antibiotic candidates include DNV3837, an antibiotic, which is in the Phase II clinical trial for the treatment of Clostridioides difficile infections. It also offers...
Where does ALDEI.PA trade?
Deinove S.A. (ALDEI.PA) trades on the Euronext Paris.
What sector is ALDEI.PA in?
Deinove S.A. (ALDEI.PA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Deinove S.A.?
Alexis Rideau is the chief executive officer of Deinove S.A. (ALDEI.PA).
Where is Deinove S.A. headquartered?
Deinove S.A. is headquartered in France.
Does ALDEI.PA pay a dividend?
Deinove S.A. (ALDEI.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALDEI.PA go public?
Deinove S.A. (ALDEI.PA) completed its initial public offering in 2010.